Authors: BIRKHEAD G BRUNDAGE J CARTTER M GERBER M HIERHOLZER W KAPLAN E MACDONALD K STEVENS D GREEN K MCGEER A SHULMAN S YOGEV R FACKLAM R GRANER J JARVIS W LEVINE O SCHWARTZ B WENGER J

Citation: G. Birkhead et al., CDC CONVENES MEETING TO DISCUSS STRATEGIES FOR PREVENTING INVASIVE GROUP-A STREPTOCOCCAL INFECTIONS, EMERGING INFECTIOUS DISEASES, 2(1), 1996, pp. 75-75

Authors: REDFIELD RR BIRX DL BRUNDAGE J ARONSON N JOHNSON S KIM J LENNOX J MICHAEL N ROBB M SITZ K OSTER C BURKE DS

Citation: Rr. Redfield et al., LONG-TERM CLINICAL FOLLOW-UP OF VOLUNTEERS ENROLLED IN AN RGP160 PHASE-1 SAFETY AND IMMUNOGENICITY VACCINE THERAPY TRIAL, AIDS research and human retroviruses, 10, 1994, pp. 190000157-190000157

Authors: LONGFIELD JN BRUNDAGE J BADGER G VIRE D MILAZZO M RAY K GEMMILL R MAGRUDER C OSTER CN ROBERTS C

Citation: Jn. Longfield et al., LOOK-BACK INVESTIGATION AFTER HUMAN-IMMUNODEFICIENCY-VIRUS SEROCONVERSION IN A PEDIATRIC DENTIST, The Journal of infectious diseases, 169(1), 1994, pp. 1-8

Authors: BIRX DL BRUNDAGE J LARSON K ENGLER R SMITH L SQUIRE E CARPENTER G SULLIVAN M RHOADS J OSTER C JAMES W LUPTON G WIERZBA T BURKE D REDFIELD R

Citation: Dl. Birx et al., THE PROGNOSTIC UTILITY OF DELAYED-TYPE HYPERSENSITIVITY SKIN TESTING IN THE EVALUATION OF HIV-INFECTED PATIENTS, Journal of acquired immune deficiency syndromes, 6(11), 1993, pp. 1248-1257